Tianjin Sian Chay Hongxing Technology Development Co., Ltd., established on 2017-02-21, Business scope includes scientific research and technical service industry;Wholesale and retail trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Shengji Group Co., Ltd., established on 1998-10-21, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Veterinary drug business;Disinfectant sales(Free of Hazardous Chemicals);Animal Husbandry and Fishery Feed Sales;Feed Additive Sales;fertilizer sales;Retailing of protective equipment for healthcare workers;Pet Food and Supplies Wholesale;Feed production special equipment sales;Refrigeration,Air Conditioning Equipment Sales;road freight transport(Does not contain dangerous goods)Non-residential real estate leases;property management;Machinery and Equipment Leasing;Car rental;Landscaping engineering construction;Import and export;Technology Import and Export;Grain Purchase;Purchase of primary agricultural products;Chinese herbal medicine acquisition.Limited to branch operations:Veterinary drug production;Disinfectant production(Free of Hazardous Chemicals);feed production;Feed additive production;Primary processing of non-edible agricultural products;fertilizer production;Manufacturing of bio-based materials.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

Hua Medicine (Shanghai) Co., Ltd. is a private company headquartered in Shanghai, China, that engages in drug development. The firm was founded in 2011 by Li Chen, who has been the CEO since then.

Shuguang Hospital is a private company headquartered in Shanghai, China, that operates as a hospital.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Longhua Hospital Shanghai University of TCM, a subsidiary of Shanghai University of Traditional Chinese Medicine, is a company headquartered in Shanghai, China. The firm provides hospital services.

Beijing Qi Yuan Yi De Pharmaceuticals Research Centre is a private company headquartered in Beijing, China, involved in pharmaceutical preparations.

Zhongyue Min'an (Beijing) Technology Development Co., Ltd., established on 2015-07-06, Business scope includes technical promotion services;Agricultural Science Research and Experimental Development;technology development,transfer;Conference Services;sell feed,Equipment;sell food.(Enterprises independently choose operating projects according to law,Carry out business activities;Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Dow Global Technologies LLC manufactures chemicals such as polymers.

Kunming Chinese Medicine Factory Co. Ltd. engages in the manufacture and development of Chinese medicines. Its business scope includes manufacture of traditional Chinese patent medicine, Chinese prepared herbal medicine, and active pharmaceutical ingredients (APIs); Chinese herbal medicine cultivation; production and sales of disinfection supplies; and processing and sales of agricultural, by-products, and Chinese medicinal materials. The company was founded in 1956 and is headquartered in Kunming, China.

Tianjin Institute of Pharmaceutical Research Co., Ltd. engages in the in the development of various new products such as innovative drugs, generic drugs, new preparations, traditional Chinese medicines, and biological drugs with particular emphasis on the engineering and industrialization of new technologies to meet drug registration requirements. The company was founded in 1959 and is headquartered in Tianjin, China.

Guangdong Yangmei Pharmaceutical Investment Co., Ltd., established on 1998-10-26, Business scope includes pharmaceutical project investment and management;medicine,Health Supplies,cosmetic,food,beverage research,to develop;Production,Sell ​​skin care,Cleansers,powder cosmetics(Operating with a valid license from the company);Sales:daily necessities,building materials;Import and export(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations must be licensed before they can be operated).

Guangdong Xinyangmei Biotechnology Co., Ltd., established on 2013-06-24, Business scope includes research in health science projects,to develop;Comprehensive retail of daily necessities;Retailing of cosmetics and hygiene products;clean up,Cleaning and daily necessities retail;Baby Products Retail;Flavors and Fragrances Retail;Soap and synthetic detergent manufacturing;Cosmetic Manufacturing;Manufacturing of Oral Cleaning Products;spices,Fragrance Manufacturing;Manufacturing of other daily chemical products(Monitor Chemicals,Excluding hazardous chemicals);Manufacture of stain removal products;Wholesale of cosmetics and hygiene products;Wholesale Cleaning Supplies;Baby Products Wholesale;Import and export(Excluding franchised products);Technology Import and Export;Human Science Research,to develop;Engineering and Technology Research and Experimental Development;

Jiangsu Jibeier Pharmaceutical Co. Ltd. engages in the research, development, preparation and manufacturing of pharmaceutical products. It mainly involves in preparation of chemical, proprietary Chinese medicine and other raw materials. The company's products cover various therapeutic areas such as improving white blood cells, enhancing immunity, treating joint diseases, anti-hypertension, anti-ocular infection, treating bronchitis, and protecting liver function. Its products include tablets, hard capsules, eye drops, gel, Likorjun tablets, Yupingfeng capsules, aceclofenacenteric-coated tablets, Nicholas tablets and other Chinese medicines. Jiangsu Jibeier Pharmaceutical was founded on November 13, 2001 and is headquartered Zhenjiang, China.

Dalian Haiyantang Biological Co., Ltd., established on 1999-04-15, Business scope includes health food,Technology research and development of food and biological products,technical consulting,technology transfer;Healthy food,freeze-dried food,Instant food,condiment,Chinese Herbal Medicine(Purification,cut),Cosmetic Manufacturing,Sales;Bred in sea water,Sales;Aquatic product acquisition,Sales;Cordyceps sinensis,ginseng,American ginseng,Ganoderma lucidum,Schisandra,Bird's nest and other foods,Sales of agricultural and sideline products;Domestic general trade;goods,Technology Import and Export;Ordinary road freight transport;General Cargo Warehousing;Biotechnology Extension Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Hailir Pesticides & Chemicals Group Co., Ltd. is engaged in the research, development, production and sale of pesticides and functional fertilizers. Its products include fungicides, herbicides, insecticides, termiticide products, bioassay and fertilizers. The company was founded on December 1, 1999 and is headquartered in Qingdao, China.

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D focused company with the highest R&D investment for several years. Hanmi has been successful for a few decades with high flexibility, continuously changing its market/development strategy from first generics to IMD & FDC (Incrementally Modified Drug and Fixed Dose Combination) to new drug development including innovative small molecules and biologics. During the period of significant changes, Hanmi made multiple strategic collaboration relationships with multinational companies and biotech companies. Based on the success in 1980s and 1990s, Hanmi started its Chinese operation in 1996 with establishment of Beijing Hanmi. Now, Beijing Hanmi grew as a well-localized and well-settled Chinese company with more than 1,300 staffs including R&D, sales / marketing, and manufacturing experts and significant growth rate higher than 20% every year. Currently, Hanmi and Beijing Hanmi is closely collaborating on various business opportunities and new drug development projects as well as sales and marketing in Chinese territories. As the only Asian company with significant presence both in Korea and China, as the most R&D focused company with number of clinical stage projects with competitiveness, and as the company with open innovation based on multiple development/marketing collaborations, Hanmi is trying to develop and provide differentiated treatment options to patients suffering from various disease.

Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.